Public biotechnology 2005--the numbers.

Lähteenmäki, Riku; Lawrence, Stacy · Nat Biotechnol · 2006

editorial · Level V

Where this comes from

Abstract

Although investors remained cautious of public biotech companies in 2005, acquisitions and research partnerships were on the up.

Medical subject headings